The Diabetes Devices market is a critical segment of the medical device industry, dedicated to empowering individuals with diabetes to effectively monitor their glucose levels and manage insulin delivery. The market is segmented into two main categories: Monitoring Devices (like Continuous Glucose Monitoring Systems/CGM, Flash Glucose Monitoring/FGM, and traditional blood glucose meters/BGM) and Insulin Delivery Devices (such as insulin pumps, smart insulin pens, and injectors). (2026-2033)
Global Diabetes Devices market is poised for robust expansion, driven by continuous innovation. Revenue is projected to climb from approximately USD 37.98 billion in 2026 to around USD 66.83 billion by 2033. This growth represents a strong Compound Annual Growth Rate (CAGR) of about 7.5% over the forecast period, reflecting high adoption rates for advanced monitoring and delivery technologies.
Showing all 6 results
-
Continuous Glucose Monitoring (CGM) Devices Market Size, Share, Trends, and Forecast (2025–2034): ...
Price range: $3,499.00 through $5,499.00Select options This product has multiple variants. The options may be chosen on the product pageReport ID : | No. of Pages : | Base Year for Estimate :The global Continuous Glucose Monitoring (CGM) Devices Market is projected to grow from USD 5.33 billion in 2025 to USD 9.93 billion by 2034, exhibiting a Compound Annual Growth Rate (CAGR) of 7.22% during the forecast period. -
Continuous Glucose Monitoring (CGM) Systems Market Analysis by Component (Sensors, Transmitters ...
Price range: $3,499.00 through $5,499.00Select options This product has multiple variants. The options may be chosen on the product pageReport ID : | No. of Pages : | Base Year for Estimate :The Continuous Glucose Monitoring (CGM) Systems Market is expected to grow at a CAGR of 17.0%, with an estimated value of around USD 12.63 billion in 2024, USD 12.4 billion in 2025, and USD 47.1 billion by 2034. -
Diabetes Management and Treatment Market Size, Share, Trends, and Forecast (2025–2034): Industry G...
Price range: $3,499.00 through $5,499.00Select options This product has multiple variants. The options may be chosen on the product pageReport ID : | No. of Pages : | Base Year for Estimate :The global diabetes care market, encompassing management and treatment, is projected to grow from $29.25 billion in 2025 to $41.21 billion by 2034, at a Compound Annual Growth Rate (CAGR) of 8.9% during the forecast period. -
Insulin Pump Therapy Market Size, Share, Trends, and Forecast (2025–2034): Industry Growth Analysi...
Price range: $3,499.00 through $5,499.00Select options This product has multiple variants. The options may be chosen on the product pageReport ID : | No. of Pages : | Base Year for Estimate :The global insulin pump therapy market is projected to grow from USD 6.45 billion in 2025 to USD 17.25 billion by 2034, exhibiting a Compound Annual Growth Rate (CAGR) of 9.65% during the forecast period. -
Non-Invasive Blood Glucose Monitoring Market Size, Share, Trends, and Forecast (2025–2034): Indust...
Price range: $3,499.00 through $5,499.00Select options This product has multiple variants. The options may be chosen on the product pageReport ID : | No. of Pages : | Base Year for Estimate :The Non-Invasive Blood Glucose Monitoring Market is projected to grow from an estimated USD 34 million in 2024 to approximately USD 316.65 million by 2034, exhibiting a robust Compound Annual Growth Rate (CAGR) of 25% during the forecast period. -
Wearable Diabetes Management Devices Market Size, Share, Trends, and Forecast (2025–2034): Industr...
Price range: $3,499.00 through $5,499.00Select options This product has multiple variants. The options may be chosen on the product pageReport ID : | No. of Pages : | Base Year for Estimate :A report on the Digital Diabetes Management Market, which includes wearable devices, estimates it to be USD 37.89 billion in 2025 and projects it to reach approximately USD 171.63 billion by 2034, expanding at a Compound Annual Growth Rate (CAGR) of 18.33% from 2025 to 2034. This broader market encompasses a significant portion of wearable diabetes management devices.